|
NIH-CMS Coordinating Committee for Trials and Data Sharing
|
Committee, Work group, Advisory group, or Task Force
|
CMS
|
NIDDK, NCATS, NCI, NIA
|
The National Institutes of Health (NIH) and the Centers for Medicare & Medicaid Services (CMS) meet periodically to discuss areas of common interest with respect to both clinical trials and research data.
|
|
NIH-CMS senior leadership Forum
|
Committee, Work group, Advisory group, or Task Force
|
CMS
|
NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/OSP
|
The CMS-NIH Senior Leadership Forum is comprised of NIH Director Francis Collins, CMS Administrator Marilyn Tavenner, and Senior Staff from both agencies. It convenes twice yearly. Meetings focus on identifying and troubleshooting areas where increased communication and specific activities (including policies and programs) will benefit the mission of both organizations. Recent topics have included creating a system for early alerts regarding NIH-supported research findings of interest to CMS; NIH-supported research findings of interest to Centers for Medicare & Medicaid Services (CMS) in high impact conditions such as diabetes, schizophrenia, post-acute stroke care, prevention of pre-term birth, lung cancer computed tomography screening, tobacco cessation, genomics, etc.; enhancing investigator access to CMS data through the use of Data Enclaves; development of common data elements (CDEs) to enhance the conduct of clinical research; and collaboration with the CMS Innovation Center to develop a Funding Opportunity Announcement , “Low Cost, Pragmatic Patient-Centered Randomized Controlled Intervention Trials,” issued and funded by NIH.
|
|
NIH-FDA Interagency Clinical Outcome Assessment Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCI, CC, NEI, NHLBI, NIA, NIAMS, NICHD, NIDDK, NIMH, NINDS, OD/DPCPSI/ODP, OD/DPCPSI/ORWH
|
The Interagency Clinical Outcome Assessments Working Group (ICOA WG) works to foster the development, evaluation, and qualification of Clinical Outcomes Assessments (COAs) for use in both medical product development and clinical research; leveraging the unique strengths, knowledge, and resources at both the Food and Drug Administration (FDA) and the NIH.
|
|
NIH-FDA Joint Leadership Council
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
OD/OSP, NCATS, NCI, NHLBI, NIAID, NIDDK, NIMH, NINDS
|
The Joint Leadership Council will work together to help ensure that regulatory considerations form an integral component of biomedical research planning, and that the latest science is integrated into the regulatory review process. Such collaboration and integration will advance the development of new products for the treatment, diagnosis and prevention of common and rare diseases and enhance the safety, quality, and efficiency of the clinical research and medical product approval enterprise. The formation of the Leadership Council represents a commitment on the part of both agencies to forge a new partnership and to leverage the strengths of each agency toward this common goal.
|
|
NIH-FDA Tobacco Regulatory Science Workgroup and Member Tobacco Training Workgroup subgroup
|
Research Initiative
|
FDA
|
OD/DPCPSI/OBSSR, NCI, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM
|
The workgroup is a forum for communication between NIH IC program staff and staff at FDA''s Center for Tobacco Products. Much of the discourse is around the development of research initiatives that fall within the scope of FDA''s regulatory authority, but are administered by NIH. The Tobacco Training Workgroup Subgroup is focussed on development of research training initiatives that fall within the scope of FDA''s CTP and are administered by NIH.
|
|
NIH-FDA Tobacco Regulatory Science Workgroup, Tobacco Training Workgroup subgroup
|
Research Initiative
|
FDA
|
NINR, NCI, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NINDS, NLM, OD/DPCPSI/OBSSR
|
The workgroup is a forum for communication between NIH IC program staff and staff at FDA''s Center for Tobacco Products. Much of the discourse is around the development of research initiatives that fall within the scope of FDA''s regulatory authority, but are administered by NIH. The Tobacco Training Workgroup Subgroup is focused on development of research training initiatives that fall within the scope of FDA''s CTP and are administered by NIH.
|
|
NIH-PEPFAR PMTCT Implementation Science Alliance
|
Other
|
CDC
|
FIC, NIAID, NICHD, NIMH, OD/DPCPSI/OAR, OD/DPCPSI/ORWH
|
Using the NIH/President''s Emergency Plan for AIDS Relief (PEPFAR) Collaboration for Advancing Implementation Science in Prevention of Maternal-Child HIV Transmission (PMTCT) request for applications (RFA) as a platform, the NIH-PEPFAR PMTCT Implementation Science Alliance promotes collaboration between implementation science researchers and program implementers and policy makers on the ground. Basing this work on actual implementation research issues rather than hypothetical examples, this project is providing a unique function, serving as the “connective tissue” over 2 years for the PIs and collaborators and program implementers on the ground. In this capacity, the Alliance is creating a forum for the network of grantees, PMTCT implementers, and policy-makers on a regular basis enabling cross-fertilization of ideas, insights and experiences as the research and the field progress.
|
|
NIH/ President''s Emergency Plan for AIDS Relief (PEPFAR) Supplement
|
Research Initiative
|
CDC, SAMHSA
|
NIAID, NIAAA, NICHD, NIDA, NIDDK
|
One-year awards for implementation science projects addressing critical questions for President''s Emergency Plan for AIDS Relief (PEPFAR) programs.
|
|
NIH/President''s Emergency Plan for AIDS Relief (PEPFAR) Collaboration for Implementation Science and Impact Evaluation
|
Research Initiative
|
CDC
|
NIAID, NCI, NICHD, NIMH, OD/DPCPSI/OAR
|
In FY11 a NIH/President''s Emergency Plan for AIDS Relief (PEPFAR) Request for Application (RFA) was issued for 3-year grant projects on Implementation Science in PEPFAR. Funding began in FY12. This RFA went out concurrently with a Centers for Disease Control and Prevention (CDC) RFA. The two agencies worked together to ensure awards were complementary and that there was no overlap.
|
|
NNI Nanotechnology Signature Initiative on Nanotechnology for Sensors and Sensors for Nanotechnology: Improving and Protecting Health, Safety, and the Environment
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NCI, NIBIB
|
Interagency effort to coordinate and stimulate creation of the knowledge, tools, and methods necessary to develop and test nanosensors and to track the fate of engineered nanomaterials in the body, consumer products, the workplace, and the environment.
|